Shanxi Zhendong Pharmaceutical Co.,Ltd (300158.SZ)
CNY 4.07
(0.25%)
CNY 4.07
(0.25%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 6.18 Billion CNY | -5.65% |
| 2022 | 6.55 Billion CNY | -35.1% |
| 2021 | 10.09 Billion CNY | 32.75% |
| 2020 | 7.6 Billion CNY | 9.95% |
| 2019 | 6.91 Billion CNY | -4.12% |
| 2018 | 7.21 Billion CNY | -5.27% |
| 2017 | 7.61 Billion CNY | 10.75% |
| 2016 | 6.87 Billion CNY | 68.89% |
| 2015 | 4.07 Billion CNY | 42.41% |
| 2014 | 2.85 Billion CNY | 2.2% |
| 2013 | 2.79 Billion CNY | 8.25% |
| 2012 | 2.58 Billion CNY | 14.54% |
| 2011 | 2.25 Billion CNY | 3.93% |
| 2010 | 2.17 Billion CNY | 237.46% |
| 2009 | 643.17 Million CNY | 29.49% |
| 2008 | 496.69 Million CNY | 6.43% |
| 2007 | 466.69 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 5.98 Billion CNY | -3.17% |
| 2024 Q2 | 5.92 Billion CNY | -1.0% |
| 2024 Q3 | 5.88 Billion CNY | -0.73% |
| 2023 FY | 6.18 Billion CNY | -5.65% |
| 2023 Q1 | 6.43 Billion CNY | -1.83% |
| 2023 Q4 | 6.18 Billion CNY | 0.65% |
| 2023 Q2 | 6.2 Billion CNY | -3.58% |
| 2023 Q3 | 6.14 Billion CNY | -0.97% |
| 2022 Q3 | 6.95 Billion CNY | -3.98% |
| 2022 Q2 | 7.24 Billion CNY | -28.3% |
| 2022 Q1 | 10.1 Billion CNY | 0.1% |
| 2022 FY | 6.55 Billion CNY | -35.1% |
| 2022 Q4 | 6.55 Billion CNY | -5.83% |
| 2021 Q1 | 7.59 Billion CNY | -0.1% |
| 2021 Q3 | 7.69 Billion CNY | 1.82% |
| 2021 FY | 10.09 Billion CNY | 32.75% |
| 2021 Q4 | 10.09 Billion CNY | 31.2% |
| 2021 Q2 | 7.55 Billion CNY | -0.52% |
| 2020 Q3 | 7.57 Billion CNY | 4.32% |
| 2020 Q1 | 7.23 Billion CNY | 4.66% |
| 2020 FY | 7.6 Billion CNY | 9.95% |
| 2020 Q2 | 7.26 Billion CNY | 0.39% |
| 2020 Q4 | 7.6 Billion CNY | 0.31% |
| 2019 Q1 | 7.34 Billion CNY | 1.89% |
| 2019 FY | 6.91 Billion CNY | -4.12% |
| 2019 Q4 | 6.91 Billion CNY | -1.89% |
| 2019 Q3 | 7.04 Billion CNY | -3.51% |
| 2019 Q2 | 7.3 Billion CNY | -0.6% |
| 2018 Q1 | 7.43 Billion CNY | -2.31% |
| 2018 Q3 | 7.4 Billion CNY | -2.13% |
| 2018 FY | 7.21 Billion CNY | -5.27% |
| 2018 Q2 | 7.56 Billion CNY | 1.7% |
| 2018 Q4 | 7.21 Billion CNY | -2.57% |
| 2017 Q3 | 7.16 Billion CNY | 0.24% |
| 2017 Q2 | 7.15 Billion CNY | 2.44% |
| 2017 Q1 | 6.98 Billion CNY | 1.56% |
| 2017 Q4 | 7.61 Billion CNY | 6.2% |
| 2017 FY | 7.61 Billion CNY | 10.75% |
| 2016 FY | 6.87 Billion CNY | 68.89% |
| 2016 Q3 | 6.9 Billion CNY | 58.52% |
| 2016 Q4 | 6.87 Billion CNY | -0.44% |
| 2016 Q1 | 4.17 Billion CNY | 2.65% |
| 2016 Q2 | 4.35 Billion CNY | 4.25% |
| 2015 Q2 | 3.14 Billion CNY | 9.08% |
| 2015 Q4 | 4.07 Billion CNY | 25.69% |
| 2015 FY | 4.07 Billion CNY | 42.41% |
| 2015 Q1 | 2.88 Billion CNY | 0.94% |
| 2015 Q3 | 3.23 Billion CNY | 2.9% |
| 2014 Q1 | 2.74 Billion CNY | -1.86% |
| 2014 FY | 2.85 Billion CNY | 2.2% |
| 2014 Q4 | 2.85 Billion CNY | -2.14% |
| 2014 Q3 | 2.92 Billion CNY | 1.2% |
| 2014 Q2 | 2.88 Billion CNY | 5.15% |
| 2013 Q2 | 2.69 Billion CNY | -0.34% |
| 2013 Q4 | 2.79 Billion CNY | 3.61% |
| 2013 Q3 | 2.69 Billion CNY | 0.34% |
| 2013 Q1 | 2.69 Billion CNY | 4.47% |
| 2013 FY | 2.79 Billion CNY | 8.25% |
| 2012 Q3 | 2.48 Billion CNY | 2.57% |
| 2012 FY | 2.58 Billion CNY | 14.54% |
| 2012 Q1 | 2.53 Billion CNY | 12.28% |
| 2012 Q2 | 2.42 Billion CNY | -4.4% |
| 2012 Q4 | 2.58 Billion CNY | 4.04% |
| 2011 Q3 | 2.33 Billion CNY | 13.55% |
| 2011 FY | 2.25 Billion CNY | 3.93% |
| 2011 Q1 | 2.06 Billion CNY | -4.72% |
| 2011 Q2 | 2.05 Billion CNY | -0.5% |
| 2011 Q4 | 2.25 Billion CNY | -3.46% |
| 2010 Q2 | 752.42 Million CNY | 0.0% |
| 2010 Q4 | 2.17 Billion CNY | 161.41% |
| 2010 FY | 2.17 Billion CNY | 237.46% |
| 2010 Q3 | 830.3 Million CNY | 10.35% |
| 2009 Q4 | 643.17 Million CNY | 0.0% |
| 2009 FY | 643.17 Million CNY | 29.49% |
| 2008 FY | 496.69 Million CNY | 6.43% |
| 2007 FY | 466.69 Million CNY | 0.0% |